» Articles » PMID: 23216996

Idiopathic Pleuroparenchymal Fibroelastosis: Consideration of a Clinicopathological Entity in a Series of Japanese Patients

Overview
Journal BMC Pulm Med
Publisher Biomed Central
Specialty Pulmonary Medicine
Date 2012 Dec 11
PMID 23216996
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Idiopathic pleuroparenchymal fibroelastosis (IPPFE) is a recently reported group of disorders characterized by fibrotic thickening of the pleural and subpleural parenchyma predominantly in the upper lobes. We report five Japanese cases fulfilling the criteria of IPPFE and address whether it should be considered a separate clinicopathologic entity. And this study was an attempt to identify features in common between IPPFE and previously described idiopathic upper lobe fibrosis (IPUF), allowing IPPFE to be considered as a distinct entity in our Japanese series.

Methods: Five consecutive cases of idiopathic interstitial lung disease confirmed as IPPFE by surgical lung biopsy were studied.

Results: There were four males and one female, aged 70±2.76 yr. No associated disorder or presumed cause was found in any case. Lung function tests found a restrictive ventilatory defect (4/5) and/or impairment of DLco (4/5). Chest X-ray showed marked apical pleural thickening in all cases. Computed tomography of the chest in all cases mainly showed intense pleural thickening and volume loss associated with evidence of fibrosis, predominantly in the upper lobes. In all cases in this study, markedly thickened visceral pleura and prominent subpleural fibrosis characterized by both elastic tissue and dense collagen were clearly shown. All cases were alive at the last follow-up, 17.6±13.59 months after diagnosis; however, all had deteriorated both clinically and radiologically.

Conclusions: IPPFE deserves to be defined as a separate, original clinicopathologic entity owing to its uniformity and IPPFE has some features in common with previously described idiopathic upper lobe fibrosis (IPUF). Our limited experience with a cohort of 5 subjects suggests that IPPFE can be rapidly progressive.

Citing Articles

Proposed Clinical Algorithm for Pleuroparenchymal Fibroelastosis (PPFE).

Yamakawa H, Oda T, Sugino K, Hirama T, Komatsu M, Katano T J Clin Med. 2024; 13(13).

PMID: 38999241 PMC: 11242275. DOI: 10.3390/jcm13133675.


Platythorax increases residual volume/total lung capacity in idiopathic pleuroparenchymal fibroelastosis.

Kinoshita Y, Takenaka S, Takata K, Utsunomiya T, Koide Y, Wada K ERJ Open Res. 2024; 10(4).

PMID: 38978546 PMC: 11228601. DOI: 10.1183/23120541.00996-2023.


Delineating associations of progressive pleuroparenchymal fibroelastosis in patients with pulmonary fibrosis.

Gudmundsson E, Zhao A, Mogulkoc N, van Beek F, Goos T, Brereton C ERJ Open Res. 2023; 9(2).

PMID: 37009018 PMC: 10052711. DOI: 10.1183/23120541.00637-2022.


Pleuroparenchymal Fibroelastosis: A Review with a Focus on a Non-Infectious Complications after Hematopoietic Stem Cell Transplant.

Arndt P Biomedicines. 2023; 11(3).

PMID: 36979903 PMC: 10046474. DOI: 10.3390/biomedicines11030924.


The world of rare interstitial lung diseases.

Buschulte K, Cottin V, Wijsenbeek M, Kreuter M, Diesler R Eur Respir Rev. 2023; 32(167).

PMID: 36754433 PMC: 9910344. DOI: 10.1183/16000617.0161-2022.


References
1.
Greene K, King Jr T, Kuroki Y, Bucher-Bartelson B, Hunninghake G, Newman L . Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis. Eur Respir J. 2002; 19(3):439-46. DOI: 10.1183/09031936.02.00081102. View

2.
Azuma A, Nukiwa T, Tsuboi E, Suga M, Abe S, Nakata K . Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2005; 171(9):1040-7. DOI: 10.1164/rccm.200404-571OC. View

3.
Frankel S, Cool C, Lynch D, Brown K . Idiopathic pleuroparenchymal fibroelastosis: description of a novel clinicopathologic entity. Chest. 2004; 126(6):2007-13. DOI: 10.1378/chest.126.6.2007. View

4.
Reddy T, Tominaga M, Hansell D, Von Der Thusen J, Rassl D, Parfrey H . Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes. Eur Respir J. 2012; 40(2):377-85. DOI: 10.1183/09031936.00165111. View

5.
Morimoto A, Mochizuki Y, Nakahara Y, Kawamura T, Sakaki S, Kobashi Y . [Case of idiopathic pulmonary upper lobe fibrosis]. Nihon Kokyuki Gakkai Zasshi. 2011; 48(12):944-9. View